Orthopediatrics (KIDS) Net Income towards Common Stockholders (2016 - 2026)

Orthopediatrics (KIDS) has reported Net Income towards Common Stockholders for 11 consecutive years, with -$10.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders changed 0.26% year-over-year to -$10.7 million; the TTM figure through Mar 2026 stood at -$39.7 million (up 2.46% YoY), while the FY2025 annual figure was -$39.6 million, down 4.83% from the prior year.
• Net Income towards Common Stockholders eased to -$10.7 million in Q1 2026 per KIDS's latest filing, from -$10.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $18.5 million in Q3 2022 and bottomed at -$16.1 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged -$6.3 million across 5 years, with a median of -$7.8 million in 2024.
• On a YoY basis, Net Income towards Common Stockholders climbed as much as 943.83% in 2022 and fell as far as 11000.0% in 2022.
• Orthopediatrics' Net Income towards Common Stockholders stood at -$7.8 million in 2022, then rose by 14.74% to -$6.7 million in 2023, then slumped by 140.16% to -$16.1 million in 2024, then soared by 37.13% to -$10.1 million in 2025, then decreased by 5.78% to -$10.7 million in 2026.
• Business Quant data shows KIDS's Net Income towards Common Stockholders at -$10.7 million in Q1 2026, -$10.1 million in Q4 2025, and -$11.8 million in Q3 2025.